Erasca, Inc. (ERAS) stock
ERASNasdaqPharmaceutical PreparationsFiscal year ends December 31
$15.66−0.12 (-0.76%)
Close on Nov 13, 2026Market cap $5.48BP/E –Yield 0.00%
Erasca ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Erasca's ebitda for the twelve months ending Sep 30, 2026 was -$324.76M. For fiscal 2025 it was -$137.80M. The highest annual figure on record is -$108.71M in fiscal 2020.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$137.80M | – |
| FY2024 | Dec 31, 2024 | -$175.78M | – |
| FY2023 | Dec 31, 2023 | -$137.79M | – |
| FY2022 | Dec 31, 2022 | -$244.81M | – |
| FY2021 | Dec 31, 2021 | -$124.05M | – |
| FY2020 | Dec 31, 2020 | -$108.71M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$58.81M | – |
| Q2 FY2026 | Jun 30, 2026 | -$46.90M | – |
| Q1 FY2026 | Mar 31, 2026 | -$187.19M | – |
| Q4 FY2025 | Dec 31, 2025 | -$31.86M | – |
| Q3 FY2025 | Sep 30, 2025 | -$33.79M | – |
| Q2 FY2025 | Jun 30, 2025 | -$37.34M | – |
| Q1 FY2025 | Mar 31, 2025 | -$34.81M | – |
| Q4 FY2024 | Dec 31, 2024 | -$34.88M | – |
| Q3 FY2024 | Sep 30, 2024 | -$36.40M | – |
| Q2 FY2024 | Jun 30, 2024 | -$66.68M | – |
| Q1 FY2024 | Mar 31, 2024 | -$37.85M | – |
| Q4 FY2023 | Dec 31, 2023 | -$32.93M | – |
| Q3 FY2023 | Sep 30, 2023 | -$33.72M | – |
| Q2 FY2023 | Jun 30, 2023 | -$35.02M | – |
| Q1 FY2023 | Mar 31, 2023 | -$36.13M | – |
| Q4 FY2022 | Dec 31, 2022 | -$137.15M | – |
| Q3 FY2022 | Sep 30, 2022 | -$36.19M | – |
| Q2 FY2022 | Jun 30, 2022 | -$35.37M | – |
| Q1 FY2022 | Mar 31, 2022 | -$36.10M | – |
| Q4 FY2021 | Dec 31, 2021 | -$30.73M | – |
| Q3 FY2021 | Sep 30, 2021 | -$45.85M | – |
| Q2 FY2021 | Jun 30, 2021 | -$28.02M | – |
| Q1 FY2021 | Mar 31, 2021 | -$19.46M | – |
| Q4 FY2020 | Dec 31, 2020 | -$66.82M | – |
| Q3 FY2020 | Sep 30, 2020 | -$11.02M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.15M | – |
See a number that looks wrong?